Cargando…
Leukocyte subtyping predicts for treatment failure and poor survival in anal squamous cell carcinoma
BACKGROUND: Anal squamous cell carcinoma (SCC) generally carries a favorable prognosis, as most tumors are highly sensitive to standard of care chemoradiation. However, outcomes are poor for the 20–30% of patients who are refractory to this approach, and many will require additional invasive procedu...
Autores principales: | Principe, Daniel R., Cataneo, Jose L., Timbers, Kaytlin E., Koch, Regina M., Valyi-Nagy, Klara, Mellgren, Anders, Rana, Ajay, Gantt, Gerald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229146/ https://www.ncbi.nlm.nih.gov/pubmed/35751111 http://dx.doi.org/10.1186/s12885-022-09742-7 |
Ejemplares similares
-
TGFβ Signaling in the Pancreatic Tumor Microenvironment
por: Principe, Daniel R., et al.
Publicado: (2021) -
Loss of SMAD4 Is Associated With Poor Tumor Immunogenicity and Reduced PD-L1 Expression in Pancreatic Cancer
por: Principe, Daniel R., et al.
Publicado: (2022) -
Progress for Immunotherapy in Inflammatory Breast Cancer and Emerging Barriers to Therapeutic Efficacy
por: Koch, Regina M., et al.
Publicado: (2021) -
Survival rate variation with different histological subtypes of poor prognostic male anal squamous cell carcinoma: a population-based study
por: Wan, Zihao, et al.
Publicado: (2017) -
Increased Resistance of Breast, Prostate, and Embryonic Carcinoma Cells against Herpes Simplex Virus in Three-Dimensional Cultures
por: Voros, Andras, et al.
Publicado: (2013)